Skip to main content

Table 2 Association between clinical characteristics and the prognosis of ESCC

From: Diet folate, DNA methylation and genetic polymorphisms of MTHFRC677T in association with the prognosis of esophageal squamous cell carcinoma

Characteristics

Total patients

Death, N(%)

HR(95% CI)†

P

Site

    

   Upper

23

13(56.52)

1

 

   Middle

64

30(46.88)

0.80(0.42-1.54)

0.507

   Low

33

15(45.45)

0.74(0.35-1.55)

0.424

TNM stage

  

   T

    

1

21

5(23.81)

1

 

2

44

15(34.09)

1.52(0.55-4.20)

0.414

3

47

31(65.96)

3.80(1.47-9.79)

0.006

4

8

7(87.50)

7.65(2.40-24.32)

0.001

   P for trend

   

< 0.001

   N

    

0

62

18(29.03)

1

 

1

58

40(68.97)

3.54(2.02-6.19)

< 0.001

   M

    

0

119

58(48.74)

1

 

1

1

0(0)

-

-

Clinical stage

    

   1/2

61

20(32.79)

1

 

   3/4

59

38(64.41)

2.83(1.64-4.87)

< 0.001

Chemo-therapy

    

   No

114

57(50.00)

1

 

   Yes

6

1(16.67)

0.25(0.03-1.79)

0.167

Radio-therapy

    

   No

91

41(45.05)

1

 

   Yes

28

17(60.71)

1.45(0.83-2.56)

0.195

  1. †: HR(95% CI), hazard ratio (95% confidence interval)